Perry Nisen

Form D signer

Perry Nisen

Chief Executive Officer at Quanta Therapeutics

Form D signer

Capital raised by Quanta Therapeutics

$76.2M+$76.2M latest round

1 Form D filing · first filed May 2023 · South San Francisco, CA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Quanta TherapeuticsBiotech · South San Francisco, CAsince May 2023

Chief Executive Officer

Signatory on Quanta Therapeutics's Form D filings · $76.2M raised across 1

Company filings

via EDGAR · Form D for Quanta Therapeutics1

DateCompanyFormAmountRole on filing

May 10, 2023Quanta TherapeuticsForm D/A+$76.2MChief Executive Officer

Form D/AMay 10, 2023 · Quanta Therapeutics+$76.2Mas Chief Executive Officer

Overview

Last filing May 10, 2023

Perry Nisen is on file as Chief Executive Officer at Quanta Therapeutics in South San Francisco, CA. Quanta Therapeutics has 1 Form D filing on record, $76.2M raised in total. Perry Nisen appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Quanta Therapeutics · 1

Cameron PittDirector

Products

Quanta Therapeutics · 1

QTX3034Clinical-stage oncology drug candidate

An oral, G12D-preferring multi-KRAS allosteric inhibitor in Phase 1 dose expansion, studied as monotherapy and in combination with cetuximab and chemotherapy in pancreatic, colorectal and endometrial cancers.